Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
You can purchase shares of Bio-Rad Laboratories (NYSE:BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS) and Waters (NYSE:WAT).
Bio-Rad Laboratories has a consensus price target of $435.14.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $327.47 last updated December 20, 2024 at 7:00 PM EST.
A quarterly cash dividend of 0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on Invalid DateTime.
Bio-Rad Laboratories’s Q4 earnings are confirmed for Thursday, February 13, 2025.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.